維港環保科技(01845.HK):放棄行使優先受讓權
格隆匯2月1日丨維港環保科技(01845.HK)發佈公吿,近日,轉讓人擬向受讓人悉數轉讓其於維港泓達的全部39.23%股權,代價為人民幣2921.43萬元。董事會於2024年2月1日通過決議案,批准(其中包括)德博環境放棄行使收購有關轉讓的股權的優先受讓權。同日,德博環境亦簽署維港泓達的股東決議案,以批准轉讓及股東由轉讓人變更為受讓人。
轉讓完成後,維港泓達將分別由德博環境、受讓人及稷勝環保持有50.27%、39.23%及10.5%,因此,公司間接持有的股權比例概無變動,而維港泓達仍將為公司的間接非全資附屬公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.